← brief for 2026-10-25 · Slowing decline
Evaluation of the preventive effect of intravenous trans-sodium crocetinate followed by oral crocetin on contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angioplasty: A randomized placebo-controlled triple-blind clinical trial.
Key takeaways
A trial of 130 people found a plant-based antioxidant helped protect kidneys. The medicine was given before a heart scan. It may lower the risk of kidney damage from the dye.
Who did this work
Salari S · Mohammadpour A · Gholoobi A · Ghavami V · Ramezani J · Eshraghi A · Hosseinzadeh H
Source
Article · PubMed, CKD progression and prevention · 2026
https://pubmed.ncbi.nlm.nih.gov/42920967/